Lou Pascarella joins Beghou Consulting as advisor

Lou Pascarella, an experience life sciences commercial operations leader, has joined Beghou Consulting, a Chicago-headquartered life sciences consultancy, as an advisor.

Based in New York, Pascarella brings more than 20 years of experience building and leading high-performing teams across commercial, R&D, business development, manufacturing and product lifecycle management.

He most recently spent two years as CEO of Innocoll, a specialty pharmaceutical company. Before that, Pascarella spent three years at Novo Nordisk, where he was head of US commercial operations.

Earlier in his career, Pascarella spent 20 years at The Janssen Pharmaceutical Companies of Johnson & Johnson, where he held various commercial leadership roles.

He has an MBA from New York University and a bachelor’s degree in psychology and business from Albright College.

“Lou brings a wealth of knowledge to our team, and we’re thrilled to have his voice in the room as we continue to work to help clients improve commercial effectiveness across the product lifecycle,” said Beth Beghou, CEO of Beghou Consulting. “Lou’s experience across therapeutic areas and with large and midsize life sciences companies, as well as emerging companies, gives him a unique vantage point on the industry that will inform our plans for innovation and growth.”

Founded in 1993, Beghou Consulting helps life sciences companies establish and manage commercial operations – with particular expertise serving emerging pharma firms. The consultancy has offerings in commercial operations support, marketing research, segmentation and targeting, sales force design, incentive compensation, forecasting, and data and analytics.

Beghou has more than 250 employees across eight offices in the US and India.

“In my career, I have built expansive commercial operations functions and integrated operations and data to enable better business decisions,” Pascarella said. “As Beghou navigates what I expect to be a consolidating industry in the years ahead, I look forward to helping them address the pressing and evolving needs of commercial leaders.”